B cell abnormality and autoimmune disorders

References

• Goodnow CC, Cyster JG, Hartley SB, Bell SE, Cooke MP, Healy JI, Akkaraju S, Rathmell JC, Pogue SL, Shokat KP. Self-tolerance checkpoints in B lymphocyte development. Adv Immunol 1995; 59: 279–368
   PubMed Web of Science ®Google Scholar
• Tsubata T, Honjo T. B cell tolerance and autoimmunity. Rev Immunogenet 2000; 2: 18–25
   PubMedGoogle Scholar
• Nemazee D. Receptor selection in B and T lymphocytes. Annu Rev Immunol 2000; 18: 19–51
   PubMed Web of Science ®Google Scholar
• Nemazee D. Receptor editing in B cells. Adv Immunol 2000; 74: 89–126
   PubMedGoogle Scholar
• Goodnow CC, Crosbie J, Jorgensen H, Brink RA, Basten A. Induction of self-tolerance in mature peripheral B lymphocytes. Nature 1989; 342: 385–391
   PubMed Web of Science ®Google Scholar
• Russell DM, Dembic Z, Morahan G, Miller JF, Burki K, Nemazee D. Peripheral deletion of self-reactive B cells. Nature 1991; 354: 308–311
   PubMed Web of Science ®Google Scholar
• Benhamou LE, Cazenave PA, Sarthou P. Anti-immunoglobulins induce death by apoptosis in WEHI-231 B lymphoma cells. Eur J Immunol 1990; 20: 1405–1407
   PubMed Web of Science ®Google Scholar
• Hasbold J, Klaus GG. Anti-immunoglobulin antibodies induce apoptosis in immature B cell lymphomas. Eur J Immunol 1990; 20: 1685–1690
   PubMed Web of Science ®Google Scholar
• Murakami M, Tsubata T, Okamoto M, Shimizu A, Kumagai S, Imura H, Honjo T. Antigen-induced apoptotic death of Ly-1 B cells responsible for autoimmune disease in transgenic mice. Nature 1992; 357: 77–80
   PubMed Web of Science ®Google Scholar
• Tsubata T, Murakami M, Honjo T. Antigen-receptor cross-linking induces peritoneal B-cell apoptosis in normal but not autoimmunity-prone mice. Curr Biol 1994; 4: 8–17
   PubMed Web of Science ®Google Scholar
• Parry SL, Hasbold J, Holman M, Klaus GG. Hypercross-linking surface IgM or IgD receptors on mature B cells induces apoptosis that is reversed by costimulation with IL-4 and anti- CD40. J Immunol 1994; 152: 2821–2829
   PubMed Web of Science ®Google Scholar
• Parry SL, Holman MJ, Hasbold J, Klaus GG. Plastic-immobilized anti-mu or anti-delta antibodies induce apoptosis in mature murine B lymphocytes. Eur J Immunol 1994; 24: 974–979
   PubMed Web of Science ®Google Scholar
• Nomura T, Han H, Howard MC, Yagita H, Yakura H, Honjo T, Tsubata T. Antigen receptor-mediated B cell death is blocked by signaling via CD72 or treatment with dextran sulfate and is defective in autoimmunity- prone mice. Int Immunol 1996; 8: 867–875
   PubMed Web of Science ®Google Scholar
• Hokazono Y, Adachi T, Wabl M, Tada N, Amagasa T, Tsubata T. Inhibitory co-receptors activated by antigens but not by anti-immunoglobulin heavy chain antibodies install requirement of co-stimulation through CD40 for survival and proliferation of B cells. J Immunol 2003; 171: 1835–1843
   PubMed Web of Science ®Google Scholar
• Tsubata T, Wu J, Honjo T. B-cell apoptosis induced by antigen receptor crosslinking is blocked by a T-cell signal through CD40. Nature 1993; 364: 645–648
   PubMed Web of Science ®Google Scholar
• Banchereau J, Bazan F, Blanchard D, Briere F, Galizzi JP, van Kooten C, Liu YJ, Rousset F, Saeland S. The CD40 antigen and its ligand. Annu Rev Immunol 1994; 12: 881–922
   PubMed Web of Science ®Google Scholar
• Matzinger P. The danger model: A renewed sense of self. Science 2002; 296: 301–305
   PubMed Web of Science ®Google Scholar
• Kozono Y, Kotzin BL, Holers VM. Resting B cells from New Zealand black mice demonstrate a defect in apoptosis induction following surface IgM ligation. J Immunol 1996; 156: 4498–4503
   PubMed Web of Science ®Google Scholar
• Yoshida T, Higuchi T, Hagiyama H, Strasser A, Nishioka K, Tsubata T. Rapid B cell apoptosis induced by antigen receptor ligation does not require Fas (CD95/APO-1), the adaptor protein FADD/MORT1 or CrmA-sensitive caspases but is defective in both MRL-+/+ and MRL-lpr/lpr mice. Int Immunol 2000; 12: 517–526
   PubMed Web of Science ®Google Scholar
• Watanabe-Fukunaga R, Brannan CI, Copeland NG, Jenkins NA, Nagata S. Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature 1992; 356: 314–317
   PubMed Web of Science ®Google Scholar
• Nagata S, Golstein P. The Fas death factor. Science 1995; 267: 1449–1456
   PubMed Web of Science ®Google Scholar
• Thornberry NA, Lazebnik Y. Caspases: Enemies within. Science 1998; 281: 1312–1316
   PubMed Web of Science ®Google Scholar
• Roy S, Nicholson DW. Cross-talk in cell death signaling. J Exp Med 2000; 192: F21–F25
   PubMed Web of Science ®Google Scholar
• Budihardjo I, Oliver H, Lutter M, Luo X, Wang X. Biochemical pathways of caspase activation during apoptosis. Annu Rev Cell Dev Biol 1999; 15: 269–290
   PubMed Web of Science ®Google Scholar
• Green DR. Apoptotic pathways: Paper wraps stone blunts scissors. Cell 2000; 102: 1–4
   PubMed Web of Science ®Google Scholar
• Tsujimoto Y. Cell death regulation by the Bcl-2 protein family in the mitochondria. J Cell Physiol 2003; 195: 158–167
   PubMed Web of Science ®Google Scholar
• Chao DT, Korsmeyer SJ. BCL-2 family: Regulators of cell death. Annu Rev Immunol 1998; 16: 395–419
   PubMed Web of Science ®Google Scholar
• Fang W, Rivard JJ, Ganser JA, LeBien TW, Nath KA, Mueller DL, Behrens TW. Bcl-xL rescues WEHI 231 B lymphocytes from oxidant-mediated death following diverse apoptotic stimuli. J Immunol 1995; 155: 66–75
   PubMed Web of Science ®Google Scholar
• Nisitani S, Tsubata T, Murakami M, Okamoto M, Honjo T. The bcl-2 gene product inhibits clonal deletion of self-reactive B lymphocytes in the periphery but not in the bone marrow. J Exp Med 1993; 178: 1247–1254
   PubMed Web of Science ®Google Scholar
• Enders A, Bouillet P, Puthalakath H, Xu Y, Tarlinton DM, Strasser A. Loss of the pro-apoptotic BH3-only Bcl-2 family member Bim inhibits BCR stimulation-induced apoptosis and deletion of autoreactive B cells. J Exp Med 2003; 198: 1119–1126
   PubMed Web of Science ®Google Scholar
• Puthalakath H, Huang DC, O'Reilly LA, King SM, Strasser A. The proapoptotic activity of the Bcl-2 family member Bim is regulated by interaction with the dynein motor complex. Mol Cell 1999; 3: 287–296
   PubMed Web of Science ®Google Scholar
• Strasser A, Whittingham S, Vaux DL, Bath ML, Adams JM, Cory S, Harris AW. Enforced BCL2 expression in B-lymphoid cells prolongs antibody responses and elicits autoimmune disease. Proc Natl Acad Sci USA 1991; 88: 8661–8665
   PubMed Web of Science ®Google Scholar
• Bouillet P, Metcalf D, Huang DC, Tarlinton DM, Kay TW, Kontgen F, Adams JM, Strasser A. Proapoptotic Bcl-2 relative Bim required for certain apoptotic responses, leukocyte homeostasis, and to preclude autoimmunity. Science 1997; 286: 1735–1738
   Web of Science ®Google Scholar
• Bouillet P, Purton JF, Godfrey DI, Zhang LC, Coultas L, Puthalakath H, Pellegrini M, Cory S, Adams JM, Strasser A. BH3-only Bcl-2 family member Bim is required for apoptosis of autoreactive thymocytes. Nature 2002; 415: 922–926
   PubMed Web of Science ®Google Scholar
• Desai-Mehta A, Lu L, Ramsey GR, Datta SK. Hyperexpression of CD40 ligand by B and T cells in human lupus and its role in pathogenic autoantibody production. J Clin Investig 1996; 97: 2063–2073
   PubMed Web of Science ®Google Scholar
• Koshy M, Berger D, Crow MK. Increased expression of CD40 ligand on systemic lupus erythematosus lymphocytes. J Clin Investig 1996; 98: 826–837
   PubMed Web of Science ®Google Scholar
• Blossom S, Chu EB, Weigle WO, Gilbert KM. CD40 ligand expressed on B cells in the BXSB mouse model of systemic lupus erythematosus. J Immunol 1997; 159: 4580–4586
   PubMed Web of Science ®Google Scholar
• Higuchi T, Aiba Y, Nomura T, Matsuda J, Mochida K, Suzuki M, Kikutani H, Honjo T, Nishioka K, Tsubata T. Cutting edge: Ectopic expression of CD40 ligand on B cells induces lupus-like autoimmune disease. J Immunol 2002; 168: 9–12
   PubMed Web of Science ®Google Scholar
• Do RK, Hatada E, Lee H, Tourigny MR, Hilbert D, Chen-Kiang S. Attenuation of apoptosis underlies B lymphocyte stimulator enhancement of humoral immune response. J Exp Med 2000; 192: 953–964
   PubMed Web of Science ®Google Scholar
• Mackay F, Schneider P, Rennert P, Browning J. BAFF and APRIL: A tutorial on B cell survival. Annu Rev Immunol 2003; 21: 231–264
   PubMed Web of Science ®Google Scholar
• Zhang J, Roschke V, Baker KP, Wang Z, Alarcon GS, Fessler BJ, Bastian H, Kimberly RP, Zhou T. Cutting edge: A role for B lymphocyte stimulator in systemic lupus erythematosus. J Immunol 2001; 166: 6–10
   PubMed Web of Science ®Google Scholar
• Cheema GS, Roschke V, Hilbert DA, Stohl W. Elevated serum B lymphocyte stimulator levels in patients with systemic immune-based rheumatic diseases. Arthritis Rheum 2001; 44: 1313–1319
   PubMed Web of Science ®Google Scholar
• Gross JA, Johnston J, Mudri S, Enselman R, Dillon SR, Madden K, Xu WF, Parrish-Novak J, Foster D, Lofton-Day C, Moore M, Littau A, Grossman A, Haugen H, Foley K, Blumberg H, Harrison K, Kindsvogel W, Clegg CH. TACI and BCMA are receptors for a TNF homologue implicated in B-cell autoimmune disease. Nature 2000; 404: 995–999
   PubMed Web of Science ®Google Scholar
• Lesley R, Xu Y, Kalled SL, Hess DM, Schwab SR, Shu HB, Cyster JG. Reduced competitiveness of autoantigen-engaged B cells due to increased dependence on BAFF. Immunity 2004; 20: 441–453
   PubMed Web of Science ®Google Scholar
• Thien M, Phan TG, Gardam S, Amesbury M, Basten A, Mackay F, Brink R. Excess BAFF rescues self-reactive B cells from peripheral deletion and allows them to enter forbidden follicular and marginal zone niches. Immunity 2004; 20: 785–798, [see comment]
   PubMed Web of Science ®Google Scholar
• Seo SJ, Fields ML, Buckler JL, Reed AJ, Mandik-Nayak L, Nish SA, Noelle RJ, Turka LA, Finkelman FD, Caton AJ, Erikson J. The impact of T helper and T regulatory cells on the regulation of anti-double-stranded DNA B cells. Immunity 2002; 16: 535–546
   PubMed Web of Science ®Google Scholar
• Tsubata T. Co-receptors on B lymphocytes. Curr Opin Immunol 1999; 11: 249–255
   PubMed Web of Science ®Google Scholar
• Nitschke L, Tsubata T. Molecular interactions regulate BCR signal inhibition by CD22 and CD72. Trends Immunol 2004
   PubMed Web of Science ®Google Scholar
• Doody GM, Justement LB, Delibrias CC, Matthews RJ, Lin J, Thomas ML, Fearon DT. A role in B cell activation for CD22 and the protein tyrosine phosphatase SHP. Science 1995; 269: 242–244
   PubMed Web of Science ®Google Scholar
• Adachi T, Flaswinkel H, Yakura H, Reth M, Tsubata T. The B cell surface protein CD72 recruits the tyrosine phosphatase SHP-1 upon tyrosine phosphorylation. J Immunol 1998; 160: 4662–4665
   PubMed Web of Science ®Google Scholar
• Tooze RM, Doody GM, Fearon DT. Counterregulation by the coreceptors CD19 and CD22 of MAP kinase activation by membrane immunoglobulin. Immunity 1997; 7: 59–67
   PubMed Web of Science ®Google Scholar
• Otipoby KL, Andersson KB, Draves KE, Klaus SJ, Farr AG, Kerner JD, Perlmutter RM, Law CL, Clark EA. CD22 regulates thymus-independent responses and the lifespan of B cells. Nature 1996; 384: 634–637
   PubMed Web of Science ®Google Scholar
• Sato S, Miller AS, Inaoki M, Bock CB, Jansen PJ, Tang ML, Tedder TF. CD22 is both a positive and negative regulator of B lymphocyte antigen receptor signal transduction: Altered signaling in CD22-deficient mice. Immunity 1996; 5: 551–562
   PubMed Web of Science ®Google Scholar
• O'Keefe TL, Williams GT, Davies SL, Neuberger MS. Hyperresponsive B cells in CD22-deficient mice. Science 1996; 274: 798–801
   PubMed Web of Science ®Google Scholar
• Nitschke L, Carsetti R, Ocker B, Kohler G, Lamers MC. CD22 is a negative regulator of B-cell receptor signalling. Curr Biol 1997; 7: 133–143
   PubMed Web of Science ®Google Scholar
• Adachi T, Wakabayashi C, Nakayama T, Yakura H, Tsubata T. CD72 negatively regulates signaling through the antigen receptor of B cells. J Immunol 2000; 164: 1223–1229
   PubMed Web of Science ®Google Scholar
• Adachi T, Wienands J, Wakabayashi C, Yakura H, Reth M, Tsubata T. SHP-1 requires inhibitory co-receptors to down-modulate B cell antigen receptor-mediated phosphorylation of cellular substrates. J Biol Chem 2001; 276: 26648–26655
   PubMed Web of Science ®Google Scholar
• Pan C, Baumgarth N, Parnes JR. CD72-deficient mice reveal nonredundant roles of CD72 in B cell development and activation. Immunity 1999; 11: 495–506
   PubMed Web of Science ®Google Scholar
• Nishizumi H, Taniuchi I, Yamanashi Y, Kitamura D, Ilic D, Mori S, Watanabe T, Yamamoto T. Impaired proliferation of peripheral B cells and indication of autoimmune disease in lyn-deficient mice. Immunity 1995; 3: 549–560
   PubMed Web of Science ®Google Scholar
• Hibbs ML, Tarlinton DM, Armes J, Grail D, Hodgson G, Maglitto R, Stacker SA, Dunn AR. Multiple defects in the immune system of Lyn-deficient mice, culminating in autoimmune disease. Cell 1995; 83: 301–311
   PubMed Web of Science ®Google Scholar
• Tsui HW, Siminovitch KA, de SL, Tsui FW. Motheaten and viable motheaten mice have mutations in the haematopoietic cell phosphatase gene. Nat Genet 1993; 4: 124–129
   PubMed Web of Science ®Google Scholar
• O'Keefe TL, Williams GT, Batista FD, Neuberger MS. Deficiency in CD22, a B cell-specific inhibitory receptor, is sufficient to predispose to development of high affinity autoantibodies. J Exp Med 1999; 189: 1307–1313
   PubMed Web of Science ®Google Scholar
• Chen C, Nagy Z, Radic MZ, Hardy RR, Huszar D, Camper SA, Weigert M. The site and stage of anti-DNA B-cell deletion. Nature 1995; 373: 252–255
   PubMed Web of Science ®Google Scholar
• Rajewsky K. Clonal selection and learning in the antibody system. Nature 1996; 381: 751–758
   PubMed Web of Science ®Google Scholar